PMCB
PharmaCyte Biotech Inc
NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY
$0.75
-1.32% today
Updated 2026-04-29
Market cap
$8.05M
P/E ratio
—
P/S ratio
12,904.41x
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
PharmaCyte Biotech Inc (PMCB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.07M | $-351596.00 | $-1.19M | $-1.19M | $-974057.00 | $-225232.00 | $-259289.00 | $-390426.00 | $-1.56M | $-4.56M | $-4.35M | $-3.34M | $-5.08M | $-2.88M | $-2.34M | $-3.33M | $-4.12M | $-3.79M | $-2.15M | $-2.98M |
| Capital expenditures | $7243.00 | $696519.00 | $21049.00 | $5080.00 | $0.00 | $5080.00 | $0.00 | $0.00 | $3.50M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.00 | $4.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | $984.00 | $17928.00 | $6.20M | $2.10M | $1.02M | $1.53M | $705678.00 | $748027.00 | $370829.00 | $77956.00 | $645406.00 | $674.00 | $478637.00 |
| Free cash flow | $-1.08M | $-1.05M | $-1.21M | $-1.19M | $-974057.00 | $-230312.00 | $-259289.00 | $-390426.00 | $-5.06M | $-4.56M | $-4.35M | $-3.34M | $-5.08M | $-2.88M | $-2.34M | $-3.33M | $-4.12M | $-3.79M | $-2.15M | $-2.98M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $20116.00 | — | — | — | — | — | — | — | — | — | — | — | — | $22.46M | $1.13M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |